Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis. (Q40690157)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

title

Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Nada Abdelmagid

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Øivind Torkildsen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

11

Trygve Holmøy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Egil Røsjø

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Jonas C Lindstrøm

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Margitta T Kampman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Lone Jørgensen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Peter Sundström

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Tomas Olsson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Linn H Steffensen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

publication date

11 July 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

14 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

395-402

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses

14 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Epstein-Barr virus and multiple sclerosis: interaction with HLA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Vitamin D status and the risk of multiple sclerosis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Understanding the joint effects of EBV and vitamin D in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Can vitamin D supplementation prevent bone loss in persons with MS? A placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Hypovitaminosis-D and EBV: no interdependence between two MS risk factors in a healthy young UK autumn cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Regulation of vitamin D homeostasis: implications for the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Vitamin D deficiency impacts on expression of toll-like receptor-2 and cytokine profile: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Cytomegalovirus seropositivity is negatively associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516654310

21 January 2018

Identifiers

DOI

10.1177/1352458516654310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325604%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference